PROGENTEC DIAGNOSTICS
LIVE

Serial Number

88258685

Owner

PROGENTEC DIAGNOSTICS, INC.

Attorney

Edwin Flores

First Use Date

Jan 11, 2019

Filing Date

Jan 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PROGENTEC DIAGNOSTICS Trademark

Serial Number: 88258685 • Registration: 6005176

PROGENTEC DIAGNOSTICS is a trademark filed by PROGENTEC DIAGNOSTICS, INC. on January 11, 2019. The trademark is classified under Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PROGENTEC DIAGNOSTICS, INC. (6 trademarks)

825 N.E. 13TH STREET, SUITE MC 302.4,
OKLAHOMA CITY, OK 73104

Entity Type: 03

Trademark Details

Filing Date

January 11, 2019

Registration Date

March 10, 2020

First Use Anywhere

January 11, 2019

First Use in Commerce

January 11, 2019

Published for Opposition

December 24, 2019

Goods & Services

Providing access to a computer database; providing on-line forums for transmission of messages among computer and mobile device users concerning patient, doctor and caregiver information in order to generate, manage and share medical information; and provision of access to databases

Business consulting and management in the field of clinical trials, namely, patient enrollment tracking and monitoring, pharmaceutical and medicine tracking; business consulting and management in the field of clinical trials, namely, compilation of statistics and clinical trial data for business purposes; preparing and placing advertisements for others; providing referrals of patients for enrollment in clinical trials; business consulting and management in the field of clinical trials, namely, clinical data management; marketing consulting, namely, designing and developing advertising and marketing for others in relation to clinical trials and medical research; online business networking services for clinical research professionals involved in the clinical study of medical products including pharmaceuticals, biologics, diagnostic tools and medical devices; management and compilation of computerized databases of clinical research professionals to provide ability to contact clinical research professionals electronically including by email to evaluate clinical study protocols, take part in clinical studies and recruit patients to take part in clinical studies; promoting public awareness of the need for improved prevention and treatment of illnesses, and for improved health care quality and efficiency; public advocacy to promote awareness of the need for assuring patients safe access to affordable medicine; promoting technical and scientific investigation, research, and experimentation in the field of advancement of the application of scientific discovery in connection with pharmaceuticals, diagnostic tools, biomarkers and medical devices; and public advocacy to promote awareness of scientific, research and medical advances

Medical and scientific research and development in the field of medicine, the prevention, treatment, management of illness and health care delivery; medical and scientific research in the field of illness and diagnosis; technical research in the field of pharmaceutical studies; pharmaceutical product evaluation; development of pharmaceutical tools, preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; medical laboratories; scientific and technological services and research and design relating thereto, namely, scientific analysis in the fields of pharmaceutical and medical device /diagnostics development; scientific research for medical purposes; design and development of computer software; research services for medical and pharmaceutical purposes; design and development of new products/services for others; design and development of computer tracking and diagnostic tools; conducting clinical trials for others; medical laboratory services; providing information about the results of clinical trials for pharmaceutical products; electronic data storage; and working on and evaluation of biomarkers and diagnostic products; and providing an online network service that enables users to share data in the field of healthcare; non-downloadable computer software provided via the Internet as an Application Service Provider ASP-hosted solution for the collection, editing, organizing, modifying, book marking, transmission, storage and sharing of data and information

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 10, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 18, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 18, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 18, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 18, 2019 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 7, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 7, 2019 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 25, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 23, 2019 PBCR
ASSIGNED TO LIE
Apr 3, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2019 CNEA
ASSIGNED TO EXAMINER
Mar 5, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2019 NWOS
NEW APPLICATION ENTERED
Jan 15, 2019 NWAP